Algo version: 0.98b
Astellas Pharma Inc is listed at the PNK Exchange
Astellas Pharma Inc [ALPMF]
PNK Sector: Healthcare Industry:Drug Manufacturers General

Is Astellas Pharma Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Astellas Pharma Inc pays dividends. Last time was Sunday 1st of June 2025 where the investors holding the stock on Friday 28th of March 2025 were paid $0.23917 per share. Over the last 21 times between 2014 and 2025, Astellas Pharma Inc has paid $4.45468 with an average of $0.21 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Astellas Pharma Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $16.72, you would have made a loss of $-7.04 per share or -42.11%

No, the average daily trading liquidity for Astellas Pharma Inc is $1 962 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Astellas Pharma Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.18, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 1.02%, which is challenging.

We have calculated the inflation risk for Astellas Pharma Inc to be low [0.5 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.